Evidence map›Paper›PMID 31054125›Full record

ArticleEuropean child & adolescent psychiatry2020

Development and psychometric properties of the "Suicidality: Treatment Occurring in Paediatrics (STOP) Risk and Resilience Factors Scales" in adolescents.

A Rodríguez-Quiroga, I Flamarique, J Castro-Fornieles, K Lievesley, J K Buitelaar, D Coghill, C M Díaz-Caneja, R W Dittmann, A Gupta, P J Hoekstra and 11 more

Abstract read
In one paragraph

Article in European child & adolescent psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Suicide resilience: A concept analysis.Frontiers in psychiatry · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

A Rodríguez-QuirogaChild and Adolescent Psychiatry Department, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), School of Medicine, Hospital General Universitario Gregorio Marañón, CIBERSAM, Universidad Complutense, Madrid, Spain.
I FlamariqueChild and Adolescent Psychiatry and Psychology Department, 2014SGR489, Institute Clinic of Neurosciences, Hospital Clinic of Barcelona, CIBERSAM, Barcelona, Spain.
J Castro-FornielesChild and Adolescent Psychiatry and Psychology Department, 2014SGR489, Institute Clinic of Neurosciences, Hospital Clinic of Barcelona, CIBERSAM, Barcelona, Spain.
K LievesleyDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK.
J K BuitelaarDepartment of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
D CoghillDepartment of Paediatrics and Psychiatry, School of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.
C M Díaz-CanejaChild and Adolescent Psychiatry Department, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), School of Medicine, Hospital General Universitario Gregorio Marañón, CIBERSAM, Universidad Complutense, Madrid, Spain.
R W DittmannPaediatric Psychopharmacology, Department of Child and Adolescent Psychiatry, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
A GuptaDepartment of Paediatric Respiratory Medicine, Kings College Hospital NHS Foundation Trust, Denmark Hill, London, UK.
P J HoekstraDepartment of Child and Adolescent Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
L KehrmannChild and Adolescent Psychiatry Department, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), School of Medicine, Hospital General Universitario Gregorio Marañón, CIBERSAM, Universidad Complutense, Madrid, Spain.
C LlorenteChild and Adolescent Psychiatry Department, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), School of Medicine, Hospital General Universitario Gregorio Marañón, CIBERSAM, Universidad Complutense, Madrid, Spain.
D Purper-OuakilHôpital Saint Eloi, Médecine Psychologique de l'Enfant et de l'Adolescent, CHRU Montpellier, Montpellier, France.
U M E SchulzeDepartment of Child and Adolescent Psychiatry/Psychotherapy, University of Ulm, Ulm, Germany.
A ZuddasChild and Adolescent Neuropsychiatry Unit, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
R SalaDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK.
J SinghDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK.
F FioriDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK.
C ArangoChild and Adolescent Psychiatry Department, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), School of Medicine, Hospital General Universitario Gregorio Marañón, CIBERSAM, Universidad Complutense, Madrid, Spain.
Paramala SantoshDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK. paramala.1.santosh@kcl.ac.uk.ORCID http://orcid.org/0000-0003-4830-5893
STOP Consortium

Funding

FP7 Health 261411Instituto de Salud Carlos III (S2010/BMD-2422 AGES)
6 · The paper itself

Abstract

Suicidality in the child and adolescent population is a major public health concern. There is, however, a lack of developmentally sensitive valid and reliable instruments that can capture data on risk, and clinical and psychosocial mediators of suicidality in young people. In this study, we aimed to develop and assess the validity of instruments evaluating the psychosocial risk and protective factors for suicidal behaviours in the adolescent population. In Phase 1, based on a systematic literature review of suicidality, focus groups, and expert panel advice, the risk factors and protective factors (resilience factors) were identified and the adolescent, parent, and clinician versions of the STOP-Suicidality Risk Factors Scale (STOP-SRiFS) and the Resilience Factors Scale (STOP-SReFS) were developed. Phase 2 involved instrument validation and comprised of two samples (Sample 1 and 2). Sample 1 consisted of 87 adolescents, their parents/carers, and clinicians from the various participating centres, and Sample 2 consisted of three sub-samples: adolescents (n = 259) who completed STOP-SRiFS and/or the STOP-SReFS scales, parents (n = 213) who completed one or both of the scales, and the clinicians who completed the scales (n = 254). The STOP-SRiFS demonstrated a good construct validity-the Cronbach Alpha for the adolescent (α = 0.864), parent (α = 0.842), and clinician (α = 0.722) versions of the scale. Test-retest reliability, inter-rater reliability, and content validity were good for all three versions of the STOP-SRiFS. The sub-scales generated using Exploratory Factor Analysis (EFA) were the (1) anxiety and depression risk, (2) substance misuse risk, (3) interpersonal risk, (4) chronic risk, and (5) risk due to life events. For the STOP-SRiFS, statistically significant correlations were found between the Columbia-Suicide Severity Rating Scale (C-SSRS) total score and the adolescent, parent, and clinical versions of the STOP-SRiFS sub-scale scores. The STOP-SRiFS showed good psychometric properties. This study demonstrated a good construct validity for the STOP-SReFS-the Cronbach Alpha for the three versions were good (adolescent: α = 0.775; parent: α = 0.808; α = clinician: 0.808). EFA for the adolescent version of the STOP-SReFS, which consists of 9 resilience factors domains, generated two factors (1) interpersonal resilience and (2) cognitive resilience. The STOP-SReFS Cognitive Resilience sub-scale for the adolescent was negatively correlated (r = - 0.275) with the C-SSRS total score, showing that there was lower suicidality in those with greater Cognitive Resilience. The STOP-SReFS Interpersonal resilience sub-scale correlations were all negative, but none of them were significantly different to the C-SSRS total scores for either the adolescent, parent, or clinician versions of the scales. This is not surprising, because the items in this sub-scale capture a much larger time-scale, compared to the C-SSRS rating period. The STOP-SReFS showed good psychometric properties. The STOP-SRiFS and STOP-SReFS are instruments that can be used in future studies about suicidality in children and adolescents.

Indexed as

AdolescentFemaleHumansMalePsychometricsReproducibility of ResultsRisk FactorsSuicideAdolescentsChildrenPsychosocialQuestionnaire development and validationResilienceRiskSuicidality

Identifiers

PMID31054125
PMCPMC7024696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.